Can you drink green tea with kidney disease? It depends on your personal
conditions. However, generally speaking, if you are in early stage of kidney
disease, you are suggested to take green tea in moderation.
If you have kidney disease, you are suggested to follow the doctor’s advice
for the proper amount that you should drink. Green tea is allowed with kidney
disease if you take it correctly.
Green tea contains high concentrations of phytonutrient polyphenols called
catechins. The leaves also contain theanine, caffeine theobromine and
theophylline. Some of its ingredients are damaged to your kidneys, if you take
much green tea.
For example, green tea is rich in caffeine. Increased caffeine food and drink
develops the risk to raise blood pressure. Elevated blood pressure will make the
blood force to blood vessel wall and increase the overwork to damaged kidney
tissues. As a result, kidney disease will aggravate with wrong choice of foods
or drinks.
Green tea can help alleviate kidney stone which is a troublesome kidney
disease. Drinking green tea is effective in hold back the growth of calcium
oxalate into crystals, which will finally develop into kidney stone. So green
tea can prevent the formation and development of kidney stone.
Green tea is also help to prevent the buildup of glycogen in the kidneys
which is the rich resource of glucose. If there are much glucose, you may have a
great risk of developing diabetes nephropathy. So the consumption of green tea
is beneficial for patients with diabetes nephropathy.
All in all, green tea is a changeable choices for Kidney Disease patients,
with different medical conditions. If you can take green tea in a right way
based on your own condition, it will make a benefit for you. Otherwise, it may
worsen your condition. Thereby, you are suggested to consult your doctor in
advance, before you try green tea.
2014年2月17日星期一
2014年2月15日星期六
How to Overcome Fatigue in Stage 4 Chronic Kidney Disease
Fatigue is a debilitating symptom or side effect experienced by many patients
on long-term dialysis. Fatigue has a considerable effect on p
atients’ health-related quality of life and is viewed as being more important than survival by some patients. There are many challenges renal providers face when attempting to reduce fatigue in dialysis patients. The lack of a reliable, valid, and sensitive fatigue scale complicates the accurate identification of this symptom. Symptoms of daytime sleepiness and depression overlap with fatigue, making it difficult to target specific therapies. Moreover, many chronic health conditions common in the long-term dialysis population may lead to the development of fatigue and contribute to the day-to-day and diurnal variation of fatigue in patients. Key to improving the assessment and treatment of fatigue is improving our understanding of potential mediators, as well as potential therapies. Cytokines have emerged as an important mediator of fatigue and have been studied extensively in cancer related fatigue. In addition, although erythropoietin stimulating agents (ESA) have been shown to mitigate fatigue, the recent controversy regarding ESA dosing in chronic kidney disease (CKD) suggests that ESA therapy may not serve as the sole therapy to improve fatigue in this population. In conclusion, fatigue is an important and often under-recognized symptom in the dialysis population. Possible interventions for minimizing fatigue in patients on long-term dialysis should be aimed at improving health care provider awareness, developing improved methods of measurement, better understanding of the pathogenesis, as well as management of known contributing factors.
Contributors to Fatigue in ESRD
In the dialysis population, physiologic, behavioral, treatment-related, and individual characteristics may be correlated with fatigue . Physiologic etiologies include anemia, malnutrition, uremia, dialysis inadequacy, hyperparathyroidism, coexisting chronic illnesses, sleep disorders, depression and side effects of medications. Dietary and fluid restriction may also play a role. Physical inactivity has been associated with higher levels of fatigue. Socio-demographic factors including age, sex, race, educational, marital, and vocational status may also play a role in the experience of fatigue in dialysis patients, In a study among HD patients in Taiwan, higher levels of fatigue were reported by female, older and unemployed patients. It is also important to note that pro-inflammatory cytokines have emerged as potential mediators of fatigue, providing a common biological pathway for physiologic, behavioral, and treatment-related factors to cause fatigue in the dialysis population.
atients’ health-related quality of life and is viewed as being more important than survival by some patients. There are many challenges renal providers face when attempting to reduce fatigue in dialysis patients. The lack of a reliable, valid, and sensitive fatigue scale complicates the accurate identification of this symptom. Symptoms of daytime sleepiness and depression overlap with fatigue, making it difficult to target specific therapies. Moreover, many chronic health conditions common in the long-term dialysis population may lead to the development of fatigue and contribute to the day-to-day and diurnal variation of fatigue in patients. Key to improving the assessment and treatment of fatigue is improving our understanding of potential mediators, as well as potential therapies. Cytokines have emerged as an important mediator of fatigue and have been studied extensively in cancer related fatigue. In addition, although erythropoietin stimulating agents (ESA) have been shown to mitigate fatigue, the recent controversy regarding ESA dosing in chronic kidney disease (CKD) suggests that ESA therapy may not serve as the sole therapy to improve fatigue in this population. In conclusion, fatigue is an important and often under-recognized symptom in the dialysis population. Possible interventions for minimizing fatigue in patients on long-term dialysis should be aimed at improving health care provider awareness, developing improved methods of measurement, better understanding of the pathogenesis, as well as management of known contributing factors.
Contributors to Fatigue in ESRD
In the dialysis population, physiologic, behavioral, treatment-related, and individual characteristics may be correlated with fatigue . Physiologic etiologies include anemia, malnutrition, uremia, dialysis inadequacy, hyperparathyroidism, coexisting chronic illnesses, sleep disorders, depression and side effects of medications. Dietary and fluid restriction may also play a role. Physical inactivity has been associated with higher levels of fatigue. Socio-demographic factors including age, sex, race, educational, marital, and vocational status may also play a role in the experience of fatigue in dialysis patients, In a study among HD patients in Taiwan, higher levels of fatigue were reported by female, older and unemployed patients. It is also important to note that pro-inflammatory cytokines have emerged as potential mediators of fatigue, providing a common biological pathway for physiologic, behavioral, and treatment-related factors to cause fatigue in the dialysis population.
2014年1月14日星期二
CKD Patients and Almonds
Helping kidneys to control body chemistry by eating a sensible diet is an
important part of managing chronic kidney disease (CKD). Being careful about
what is eaten can reduce the amount of fluid and waste build-up, helping to
minimise symptoms and side effects of CKD.
Your dietary needs change with the different stages of your kidney failure. Other than reducing salt and fat intake, there is no standard kidney disease diet.
Almonds have many health benefits and are a kind of preferred food for many patients.However,can patients with stage 3 kidney failure eat almonds as they have many restrictions on diet?
Almonds are of highly nutritious and of high medical values. It contains rich protein, fat, sugar, carotene, B vitamins, vitamin C, vitamin P as well as calcium, phosphorus, iron, etc.
Almonds are good for controlling high blood sugar. Sweet almonds contain rich fibers which can make patients have full feeling and help control body weight. Bitter almonds can help prevent and treat diabetes caused by anti-tumor drug alloxan.
Almonds also have beauty effect by promoting blood circulation of the skin.
Eating almonds help treat inflammations and ease pains.
Almonds also have anti-oxidant and anti-tumor properties.
Almonds can alleviate digestive disorders. Almonds contain fatty oil and it has the role of embellish aperient bowel and it can be used to alleviate constipation.
Considerations
As almonds have so many health benefits,they are recommended to patients with stage 3 kidney failure.However,it is important for them to keep moderated consumption. What is the recommended daily consumption of almonds for people with stage 3 kidney failure? Chat with our online doctor for advices.
Your dietary needs change with the different stages of your kidney failure. Other than reducing salt and fat intake, there is no standard kidney disease diet.
Almonds have many health benefits and are a kind of preferred food for many patients.However,can patients with stage 3 kidney failure eat almonds as they have many restrictions on diet?
Almonds are of highly nutritious and of high medical values. It contains rich protein, fat, sugar, carotene, B vitamins, vitamin C, vitamin P as well as calcium, phosphorus, iron, etc.
Almonds are good for controlling high blood sugar. Sweet almonds contain rich fibers which can make patients have full feeling and help control body weight. Bitter almonds can help prevent and treat diabetes caused by anti-tumor drug alloxan.
Almonds also have beauty effect by promoting blood circulation of the skin.
Eating almonds help treat inflammations and ease pains.
Almonds also have anti-oxidant and anti-tumor properties.
Almonds can alleviate digestive disorders. Almonds contain fatty oil and it has the role of embellish aperient bowel and it can be used to alleviate constipation.
Considerations
As almonds have so many health benefits,they are recommended to patients with stage 3 kidney failure.However,it is important for them to keep moderated consumption. What is the recommended daily consumption of almonds for people with stage 3 kidney failure? Chat with our online doctor for advices.
订阅：
博文 (Atom)